Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...

That candidate hits the same target as Elahere, the ADC that AbbVie acquired in its $10 billion takeover of ImmunoGen. Elahere received full FDA approval in ovarian cancer this year, but ...

The biotech company also reiterated its 2023 revenue forecast of $45M to $50M, excluding revenue generated by Elahere. Operating expenses are anticipated in the $350M to $365M range.

An international team of researchers from the University of Turku, Finland, and the University of Tours, France, aimed to validate the use of infrared thermal imaging as a non-invasive tool for ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...

Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

Recombinant DNA is one of the first stories in modern biotechnology history. The National Museum of American History contains collections which trace this foundational technique of genetic engineering ...

Biotechnology has proven to be a real problem-solver for some big challenges in our lives — from producing the insulin that people with diabetes need to regulate their blood sugar to manufacturing ...

The PhD in Biotechnology program is a completely new approach to doctoral learning. Designed to train a robust life sciences workforce, the program will create new opportunities for commercialization ...

The fall flurry of biotech IPOs shows no signs of abating, with Upstream Bio becoming the latest company to express an intention to go public. The Waltham, Massachusetts-based biotech has yet to ...

Apr. 23, 2024 — Researchers describe the steps they took to manipulate DNA and proteins -- essential building blocks of life -- to create cells that look and act like cells from the body. This ...